Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized to make diagnostics more accessible at the front lines of healthcare. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need. The company’s leaders, with backgrounds in international business and biomedical engineering, have decades of success in developing and delivering more than 60 products that have made a difference in people’s lives. We leverage our experience in building successful medical products to solve major needs in global health. Our low-cost technologies are targeted for the developing world and can impact millions by identifying diseases which can be affordably treated. Hemex is developing a diagnostic platform (utilizing technology which received a 2016 Patents for Humanity Award) that can quickly and easily diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a drop of blood. The solution provides point-of-care access to diagnostic information faster, more cost-effectively, and more accurately than any solution on the market today. Hemex is an equal opportunity employer. All employment-related decisions are based solely upon one’s individual merit and qualifications directly related to professional competence, and without regard to race, color, religion, national origin, pregnancy status, sex (gender}, age, marital status, mental or physical disability, sexual orientation, gender identity, military or veteran status, genetic history, or any other characteristic or classification protected by applicable law. We will also attempt to reasonably accommodate an individual based on his/her physical or mental limitation or because of the individual’s sincerely held religious beliefs.